DeutschNewstral
Article
Fft.com on 2016-10-26 10:51
Pharmaceuticals: Bayer raises profit target after strong pharma earnings
Related news
- FPharmaceuticals: Novo Nordisk’s shares plunge after it slashes profit targetft.com
- FBayer raises full-year earnings targetft.com
- FBayer raises forecasts as pharma buoys 3Q earningsft.com
- FBanks: Morgan Stanley edges closer to profit target as earnings jumpft.com
- FPharmaceuticals: Pfizer cancels cholesterol drug trial and cuts earnings forecastft.com
- FStrong pharmaceuticals earnings boost Bayer profitsft.com
- FNovo Nordisk slashes profit target, shares plungeft.com
- FCorporate earnings: Japan’s Sharp targets first profit in 3 yearsft.com
- FCorporate earnings: US earnings boost hopes that profit recession is endingft.com
- FLafargeHolcim announces $990m share buyback but trims 2018 earnings targetft.com
- FUS tech buoyed as investors target earnings growthft.com
- FPharmaceuticals: AstraZeneca walks tightrope of drug trialsft.com
- FPharmaceuticals sector: WuXi AppTec lobbies against US bill that aims to restrict Chinese pharma groupsft.com
- FPharmaceuticals: J&J prepares for drug price war with Pfizerft.com
- LCeftiofur Market: Size, Growth, Facts, Figures and Trends 2021-2027 | Top Vendors : Pfizer, Cephazone Pharma, AN PharmaTech, Novartis, Zoetis, Cadila Pharmaceuticals, HIPRA, Bayer, Norbrook Laboratâ¦.liverpoolstudentmedia.com
- FGilead in $11.9bn deal for Kite Pharmaft.com
- FPharma industry faces hypocrisy charge over patentsft.com
- FPharma companies argue against new UK regulatorft.com
- FPharma lobbies against US states curbing pricesft.com